New tool to improve blood pressure measurement

 

  • Scientists at Oxford University have developed a new way of estimating our true underlying blood pressure that overcomes common problems in a clinical setting which can lead to misleading results.

 

Oxford, UK (March 21,2016) – Scientists at Oxford University have developed a new way of estimating our true underlying blood pressure that overcomes common problems in a clinical setting which can lead to misleading results. Their work is published in the journal Hypertension.


Blood pressure measurement is frequently used by medics to understand our health, and dangerously high blood pressure (hypertension) can lead to serious conditions like heart attack or stroke. Blood pressure levels fluctuate throughout the day and can easily change as a result of stress, physical activity and even talking. Readings are usually taken in a doctor’s clinic, but these measurements are often different from those taken at home, which are considered to be more reflective of your true underlying blood pressure level.

 

Study leader Dr James Sheppard said: ‚One phenomenon where readings are higher in the clinic than at home is referred to as the ‚white coat effect‘. This can lead to people being started on blood pressure lowering treatments they do not really need. A reverse effect is also seen – some patients have lower readings in the clinic than they would in normal life, meaning that they can miss out on treatment that they could potentially benefit from. Understanding and accounting for the scale of these home-clinic differences would improve diagnosis and treatment.‘

 

The team therefore analysed data from more than 2000 patients, looking at factors including age, gender, body mass index, alcohol consumption and tobacco use. They also studied a number of ‚blood pressure characteristics‘ from multiple readings taken in the clinic, including the difference between the first and last readings and the rate of change in blood pressure among others. Data from around 900 patients was used to build a model, identifying factors that affected the difference between home and clinic blood pressure readings. The model was then validated by checking against the data from the other patients in the study.

 

The result is a prediction model that uses three separate blood pressure readings taken in a single consultation and basic patient characteristics to give an adjusted blood pressure reading that is significantly more accurate than existing models for identifying hypertension.

 

Dr Sheppard explained: ‚We compared the accuracy of our model to the current UK NICE guidelines and those in use in the USA, Canada and Europe. It correctly classified 93% of cases, compared to the next best, the NICE guidelines, which correctly classified 78% of patients.

 

‚Correctly classifying people as hypertensive or not is important for patients – ensuring that those who need treatment get it. Perhaps just as importantly, this approach prevents those patients displaying a white coat effect from being put on treatment which they don’t really need. This approach has the potential to save large amounts of money for the NHS by avoiding unnecessary treatment in those with the white coat effect. It may also lead to fewer patients suffering from heart attacks and stroke, by treating patients‘ blood pressure more effectively.‘

 

 

 

While the equation is complex, the team have created an online calculator for health professionals, which is available at https://sentry.phc.ox.ac.uk/proof-bp.

 

 


University of Oxford, 21.03.2016 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…